Tenet Healthcare Corporation beat EPS estimates 100% of the time across 16 reported quarters (16 beats, 0 misses), averaging +34.6% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $4.08 | $6.12 | +50.0% | Beat | Q2 FY26 call |
| Q1 FY26 | $4.21 | $4.82 | +14.5% | Beat | Q1 FY26 call |
| Q4 FY25 | $4.08 | $4.70 | +15.2% | Beat | Q4 FY25 call |
| Q3 FY25 | $3.33 | $3.70 | +11.1% | Beat | |
| Q2 FY25 | $2.84 | $4.02 | +41.5% | Beat | Q2 FY25 call |
| Q1 FY25 | $3.11 | $4.36 | +40.2% | Beat | |
| Q4 FY24 | $2.93 | $3.44 | +17.4% | Beat | |
| Q3 FY24 | $2.33 | $2.93 | +25.8% | Beat | |
| Q2 FY24 | $1.89 | $2.31 | +22.2% | Beat | |
| Q1 FY24 | $1.45 | $3.22 | +122.1% | Beat | |
| Q4 FY23 | $1.58 | $2.68 | +69.6% | Beat | |
| Q3 FY23 | $1.20 | $1.44 | +20.0% | Beat |
Back to THC overview · THC holders · THC KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.